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It has been well established that certain types of DNA
damage—for example, UV-induced pyrimidine di-
mers—block the progression of RNA polymerase. Evi-
dence suggesting a relationship between DNA repair and
transcription was presented by Mayne and Lehmann
(1982), who observed that the recovery of RNA syn-
thesis was more rapid than the overall time course of
DNA repair in UV-irradiated human cells. In addition,
it was found that, whereas Cockayne syndrome (CS)
cells were able to perform normal levels of repair syn-
thesis, they were unable to recover their RNA synthesis
after UV irradiation. Thus, it was suggested that the
defect in CS cells resides in the repair of damage in tran-
scribed genes. There is now a large body of evidence
showing that damage produced by UV and certain chem-
ical carcinogens is repaired more rapidly in transcrip-
tionally active DNA than in the genome as a whole. This
rapid repair has been shown to be due to a faster repair
of damage in the transcribed strand than in the non-
transcribed strand, in both hamster and human genes
(Mellon et al. 1987; Leadon and Lawrence 1991). Al-
though the original demonstration of such strand-spe-
cific repair of UV damage was made for mammalian
cells, it has now also been demonstrated in Escherichia
coli (Mellon and Hanawalt 1989) and Saccharomyces
cerevisiae (Smerdon et al. 1990; Leadon and Lawrence
1992; Sweder and Hanawalt 1992) and hence appears
to be a highly conserved pathway for excision repair.
The Signal
It has been proposed that the presence of an RNA
polymerase stalled at a lesion on the transcribed strand
serves as a signal that directs repair to that strand (Mel-
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lon et al. 1987). Evidence for just such a mechanism has
been found in E. coli, in which strand-selective repair is
known to depend on the Mfd protein, which appears to
displace stalled RNA polymerase from a DNA lesion,
bind the UvrA subunit of the excision nuclease, and stim-
ulate the repair of the transcribed strand (Selby and San-
car 1993). Whether the coupling of transcription and
repair occurs by a similar mechanism in eukaryotic cells
is not yet known. However, strand selectivity of repair
in both human and yeast cells has been shown to depend
on active transcription by RNA polymerase II. The faster
rate of repair of the transcribed strand of a gene cor-
relates with the level of transcription of that gene, and
this can be abolished by treatment with a-amanitin, an
inhibitor of RNA polymerase II, under conditions that
do not effect overall levels of DNA repair (Leadon and
Lawrence 1991). In addition, studies with S. cerevisiae
strains carrying a temperature-sensitive mutation in one
of the subunits of RNA polymerase II have directly dem-
onstrated the dependence of strand-specific repair on
transcription by RNA polymerase (Leadon and
Lawrence 1992; Sweder and Hanawalt 1992).
The generality of transcription-coupled repair (TCR)
for damage other than that induced by UV has only
recently been established. It has been demonstrated for
bulky adducts produced by certain chemical carcinogens
(Leadon and Lawrence 1991), suggesting that nucleo-
tide-excision repair (NER) of bulky lesions in general
may be targeted preferentially to the transcribed strand.
However, methylated purines formed by treatment of
cells with dimethyl sulfate are removed equally rapidly
from both strands of the dihydrofolate reductase gene
and from a transcriptionally silent downstream sequence
(Scicchitano and Hanawalt 1989). Since such damage is
primarily removed by specific N-glycosylases, this result
was interpreted as suggesting that repair initiated by
means other than nucleotide excision is not subject to
targeting to transcribed strands. In contrast, TCR of
thymine glycols formed in yeast by treatment with hy-
drogen peroxide has been demonstrated (Leadon and
Lawrence 1992). However, since this damaged base can
be recognized in vitro not only by a specific N-glyco-
sylase but also by the E. coli UvrABC complex (Lin and
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Sancar 1989), it was unclear whether its preferential re-
pair in yeast is performed by the same NER complex as
that involved in UV-induced pyrimidine dimers. Subse-
quently, my colleagues and I have demonstrated that
human and yeast cells defective in the NER pathway still
repair oxidative DNA damage preferentially in active
genes (Leadon and Cooper 1993; Cooper et al. 1997;
Leadon et al. 1995). These results show that TCR can
occur in the absence of NER and that repair of oxidative
DNA damage initiated by an N-glycosylase can be cou-
pled to transcription.
CS
CS is a rare sun-sensitivity disorder with a recessive
inheritance pattern. It is characterized by severe growth
defects, with cachexia, neuronal demyelination, mental
retardation, microcephaly, skeletal and retinal abnor-
malities, and dental caries but no cancer predisposition.
More than 140 cases of CS have been reported, and cells
from affected individuals define five complementation
groups. Most patients exhibit only CS symptoms and
belong to groups CS-A and CS-B. The CSA gene codes
for a protein belonging to the WD-repeat family (Hen-
ning et al. 1995), whose members regulate diverse cel-
lular functions, including cell division, signal trans-
duction, mRNA modification, and transcription. The
product of the CSB gene (Troelstra et al. 1992) contains
a region of multiple ATPase/putative helicase motifs
characteristic of the expanding and diverse SNF2 protein
family. Members of this family can have roles in chro-
matin remodeling or maintenance, activation or repres-
sion of transcription, and DNA recombination or repair.
The gene products defective in CS are required for
the TCR of both UV-induced and ionizing radia-
tion–induced DNA (Leadon and Cooper 1993; Venema
et al. 1990). Since CSB encodes a putative helicase
(Troelstra et al. 1992), its product may unwind DNA
and, thus, displace a stalled RNA polymerase complex
from the DNA, allowing repair proteins access to the
lesion. It is also possible that the CSA gene product acts
as a general mediator that recruits repair proteins to the
damaged site. Since the sole representatives of CS groups
A and B mutants studied so far are equally devoid of
the ability to target repair of UV damage to active genes
(Leadon and Cooper 1993; Venema et al. 1990), the
requirement for both gene products in this process ap-
pears to be absolute in mammalian cells. However, the
finding that the CSA mutant cell line is only partially
defective in preferential repair of ionizing-radiation
damage provides the first evidence of separable roles for
the two gene products (Leadon and Cooper 1993).
In very rare cases, complementation analyses have as-
signed some CS patients to XP group B, D, or G; some
of these XP/CS patients also present an XP phenotype.
The XPB (Weeda et al. 1990) and XPD (Flejter et al.
1992) genes code for DNA helicases with DNA-depen-
dent ATPase activity that are components of the tran-
scription-factor complex TFIIH. The TFIIH complex
corrects the repair defects in XPB and XPD cell extracts
(van Vuuren et al. 1994). TFIIH appears to play a critical
role in promoter clearance, a broadly defined event that
results in the transition of a transcription-initiation com-
plex to an elongation complex. Association of TFIIH
with the transcription complex allows for the phos-
phorylation of the carboxy-terminal domain of RNA
polymerase II and, possibly, for local unwinding of the
DNA, using the helicase activity of XPB (Goodrich and
Tjian 1994). When promoter clearance occurs, the tran-
scription-initiation factors, including TFIIH, are re-
leased, triggering transcriptional elongation by RNA
polymerase II. Thus, it is possible that an RNA poly-
merase II stalled at a DNA lesion may recruit the reas-
sembly of additional factors—for example, TFIIH—that
facilitate repair of the DNA lesion and allow resumption
of transcription after the repair of the lesion. This may
occur through the formation of a quaternary complex
containing RNA polymerase II/CSB/DNA/RNA (Tantin
1998).
Xeroderma Pigmentosum Group G
The xeroderma pigmentosum group G (XPG) gene
(Scherly et al. 1993) encodes a large protein with an
endonuclease activity that is required for making the 3′
incision in NER. XPG and Schizosaccharomyces pombe
Rad2 define two related families of nucleases (Macinnes
et al. 1993; Scherly et al. 1993). Rad2 is closely related
to human DNaseIV and to S. cerevisiae RAD27. These
∼43-kD enzymes resemble the 5′ nuclease domains of
bacterial DNA polymerases and are able to cleave DNA
flap structures to remove unpaired 5′ regions. The second
group comprises much larger proteins, of 1120 kD, and
includes human XPG and its yeast homologues, the S.
cerevisiae RAD2 and S. pombe rad13 proteins. Both
XPG and RAD2 are structure-specific endonucleases
that nick damaged DNA 3′ to the lesion, in an early step
of NER (O’Donovan et al. 1994). Unlike XPB and XPD,
the product of the XPG gene (Macinnes et al. 1993;
Scherly et al. 1993) has no documented role in
transcription.
My colleagues and I have found that XP-G patients
who exhibit a mild XP phenotype and no other clinical
symptoms display normal levels of TCR of oxidative
DNA damage (Cooper et al. 1997). The causative mu-
tations in these patients have been identified in both
XPG alleles, with the maternal allele resulting in a full-
length protein with a missense mutation in the presumed
active site of the endonuclease (Nouspikel and Clarkson
1994; Nouspikel et al. 1997). Normal levels of TCR
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were present in these mutant cells, even though the cat-
alytic activity of the XPG protein was absent. By con-
trast, we found that patients with severe infantile CS
(Vermeulen et al. 1993) show a complete loss of strand-
selective repair of oxidative DNA damage (Cooper et al.
1997). These patients have mutations that would lead
to severely truncated XPG proteins (Nouspikel et al.
1997). Therefore, TCR of oxidative damage requires a
function of the XPG protein that is distinct from its
endonuclease activity that is generally associated with
NER (O’Donovan et al. 1994). The defect in TCR cor-
relates with truncations of the XPG protein that also
lead to the clinical presentation of severe CS. The XPG
homologue in yeast, RAD2, also participates in TCR of
oxidative DNA damage; however, there is not an ab-
solute requirement for RAD2 in TCR, whereas there is
for XPG in human cells (Leadon et al. 1995). Thus, one
interpretation of these results is that inefficient repair of
endogenous oxidative base damage in critical active
genes results in the developmental defects associated
with CS.
DNA Mismatch Repair
In both prokaryotes and eukaryotes, DNA mismatch
repair plays a prominent role in the correction of errors
made during DNA replication and genetic recombina-
tion. In E. coli, the methyl-directed mismatch repair in-
volves the products of the mutator genes mutS, mutL,
mutH, and uvrD. In vitro, MutS is a DNA mis-
match–binding protein, UvrD is DNA helicase II, and
MutH is an endonuclease that incises at the transiently
unmethylated DNA strand (Modrich and Lahue 1996).
No biochemical activity for MutL has been identified.
Mutations in MutS and MutL—but not MutH—result
in a loss of strand-selective repair of UV damage, im-
plicating a role for these proteins in TCR (Mellon and
Champe 1996). However, the addition of either MutS
or MutL to an in vitro NER assay does not affect the
efficiency of lesion removal (Selby and Sancar 1995).
In eukaryotes, the mismatch-repair system is more
complex. Genetic studies have demonstrated that the
major DNA mismatch–repair pathway in S. cerevisiae
requires three bacterial MutS homologues—MSH2,
MSH3, and MSH6—and two bacterial MutL homo-
logues—MLH1 and PMS1. Human homologues of the
yeast mismatch-repair genes hMSH2, hMLH1, and
hPMS2 have been identified and have been shown to be
mutated in patients and their kindreds with hereditary
nonpolyposis colon cancer (HNPCC). Tumors from pa-
tients with HNPCC have high mutation rates in micro-
satellite sequences, a hallmark of cells with defective mis-
match repair.
Human tumor cells defective in either hMSH2,
hMLH1, or hPMS2 have been reported to show loss of
TCR of UV damage, further strengthening the link be-
tween TCR and mismatch repair (Leadon and Avrut-
skaya 1997; Mellon and Champe 1996). Similarly, hu-
man cells defective in the hMSH2 gene have been
reported to be deficient in the removal of oxidative DNA
damage, including thymine glycols, from the transcribed
strand of an active gene (Leadon and Avrutskaya 1997).
However, an hMLH1 mutant showed normal levels of
TCR of oxidative DNA damage. These results provide
the first evidence for a protein, hMLH1, that is abso-
lutely required for the removal of UV-induced DNA
damage—but not for the removal of oxidative DNA
damage—from the transcribed strand of an active hu-
man gene. No defects in TCR of UV damage are found
in yeast mutants for the MSH2, MLH1, PMS1, and
MSH3 mismatch-repair genes (Leadon and Avrutskaya
1998; Sweder et al. 1996), suggesting some functional
differences between the yeast and human mismatch-re-
pair proteins. By comparison, the yeast MSH2, MLH1,
and PMS1 gene products participate in the TCR of thy-
mine glycols (Leadon and Avrutskaya 1998). However,
in contrast to the roles of these gene products in DNA
mismatch repair, only double mutants in the MLH1 and
PMS1 genes are deficient in TCR of thymine glycols.
Cells with mutations in either MLH1 or PMS1 show
near-normal levels of TCR of oxidative DNA damage.
Surprisingly, although it appears that, in vitro, there is
no functional overlap between the human mismatch-
repair system and NER, with respect to either damage
recognition or removal (Mu et al. 1997), physical in-
teractions between yeast MSH2 and components of
NER have recently been demonstrated (Bertrand et al.
1998).
DNA mismatch repair could play at least two roles
in TCR. First, mismatch-repair proteins might ensure the
fidelity of repair of damage in an active gene by removing
errors introduced during DNA repair synthesis. Factors
involved in either transcription or repair could serve as
strand-discrimination signals for mismatch repair. How-
ever, this model would not account for a reduction in
lesion removal in mismatch-repair mutants. An alter-
native, although not mutually exclusive, role for mis-
match repair as a general sensor for DNA damage is
supported by the finding that TCR is reduced in DNA
mismatch–repair mutants. The human hMSH2 protein
appears to be a crucial component for the sensing of
DNA damage by the mismatch-repair system, since TCR
of both UV and oxidative DNA damage in hMSH2 mu-
tants is slower or absent on the transcribed strand of an
active gene. Thus, hMSH2 could bind to the DNA in
the vicinity of the stalled transcriptional complex, in a
manner similar to the way in which it recognizes and
corrects base-base mispairs and small nucleotide inser-
tion/deletion mispairs. It could then recruit other repair
proteins, including hMSH6, hMLH1, and hPMS2.
1262 Am. J. Hum. Genet. 64:1259–1263, 1999
BRCA1
Germ-line mutations in the BRCA1 gene are associ-
ated with predisposition to breast and ovarian cancer
and account for approximately half of the inherited cases
of these diseases. The loss of the wild-type BRCA1 allele
during neoplastic transformation in these patients in-
dicates that BRCA1 functions as a tumor suppressor. On
the basis of its association with Rad51, it has been sug-
gested that BRCA1 acts in concert with DNA repair
enzymes to maintain the integrity of the genome during
periods of rapid growth (Scully et al. 1997b). BRCA1
also binds to RNA polymerase II and several transcrip-
tion factors, including TFIIF, TFIIE, and TFIIH (Scully
et al. 1997a). This association could reflect BRCA1’s
proposed function as a transcriptional regulatory pro-
tein. However, this finding also suggests an involvement
of BRCA1 in TCR.
My colleagues and I have recently shown that mouse
embryonic stem cells deficient in BRCA1 are defective
in the ability to perform TCR of oxidative DNA dam-
age—but not in the ability to perform TCR of UV-in-
duced damage (Gowen et al. 1998). However, we cannot
distinguish between a direct role for BRCA1 in TCR and
a role as a transcription factor essential for the expres-
sion of genes whose products are required for TCR. If
BRCA1 serves as a transcription factor to facilitate TCR,
then it would have to modulate a very rapid transcrip-
tional activation of the required genes, since differences
in the rates of repair between the transcribed and non-
transcribed strands are found <15–30 min after treat-
ment. In addition, the genes activated by BRCA1 would
need to be specific for the repair of oxidative DNA dam-
age, since BRCA1 is not required for TCR of UV-induced
damage. Therefore, it seems more likely that BRCA1
has a direct role in TCR, possibly in recruiting specific
repair proteins. Both the early embryonic death of
Brca12/2 embryos and the importance of this gene in
tumorigenesis are consistent with a role for BRCA1 and
TCR in the growth and development of normal cells
(Gowen et al. 1996). Deficits in TCR of endogenous
oxidative damage could lead to inefficient transcription
and the accumulation of mutations in critical genes and,
ultimately, to inadequate growth during early develop-
ment. In adult tissue, an inability to target repair of
oxidative DNA damage to active genes could lead to
uncontrolled growth during tumorigenesis.
Future Directions
The study of TCR is in an exciting phase. Many of
the genes identified as being required for TCR are as-
sociated with specific human diseases and clinical phe-
notypes; for example, defects in CSA and CSB, as well
as certain mutations in XPG, all share the hallmark of
developmental defects. By comparison, both defects in
DNA mismatch–repair proteins and BRCA1 lead to in-
creases in tumors in specific tissues. Therefore, an im-
portant area of future investigation will be to determine
how these proteins interact with each other. In addition,
since some of the proteins involved in TCR perform
multiple functions in the cell, it will be important to
begin to map which regions of the proteins are required
for TCR and which are required for other cellular pro-
cesses. These types of studies should begin to provide
not only valuable insights into the relationship between
TCR and specific human diseases but also new targets
for antitumor agents.
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